Odyssey Health (ODYY) Common Equity (2014 - 2026)

Odyssey Health's Common Equity history runs 13 years deep, the most recent figure standing at -$9.7 million for Q2 2026.

• On a quarterly basis, Common Equity fell 245.46% year-over-year to -$9.7 million in Q2 2026; TTM through Apr 2026 was -$9.7 million, a 245.46% decrease from a year earlier, with the FY2025 full-year figure at -$7.0 million, down 30.39% from the prior year.
• Common Equity improved to -$9.7 million in Q2 2026 per ODYY's latest filing, from -$10.6 million in the prior quarter.
• Across five years, Common Equity topped out at $8.7 million in Q1 2024 and bottomed at -$10.6 million in Q1 2026.
• The 5-year median for Common Equity is -$5.6 million (2022), against an average of -$4.0 million.
• Across the five-year window, Common Equity plunged 330.85% in 2022 and surged 261.56% in 2024, its largest moves.
• Year by year, Common Equity stood at -$5.4 million in 2022, then dropped by 15.5% to -$6.2 million in 2023, then dropped by 0.97% to -$6.3 million in 2024, then decreased by 13.96% to -$7.2 million in 2025, then tumbled by 36.26% to -$9.7 million in 2026.
• Per Business Quant, the three latest ODYY Common Equity figures stand at -$9.7 million (Q2 2026), -$10.6 million (Q1 2026), and -$7.2 million (Q4 2025).